Athira Pharma
ATHA
ATHA
75 hedge funds and large institutions have $59.5M invested in Athira Pharma in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more capital invested
Capital invested by funds: $53.3M → $59.5M (+$6.12M)
1.09% less ownership
Funds ownership: 57.25% → 56.15% (-1.1%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
75
Holding in Top 10
–
Calls
$269K
Puts
$119K
Top Buyers
| 1 | +$1.11M | |
| 2 | +$623K | |
| 3 | +$492K | |
| 4 |
Jane Street
New York
|
+$340K |
| 5 |
Two Sigma Investments
New York
|
+$333K |
Top Sellers
| 1 | -$1.52M | |
| 2 | -$861K | |
| 3 | -$822K | |
| 4 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
-$370K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$342K |